TP53 and cancer: Using these approaches, we showed that the overall frequency of ERMS self-renewing cancer stem cells was unaffected by loss of tp53. In contrast, tp53del/del ERMS were more invasive, providing a potential explanation for increased aggression associated with TP53 disruption in human ERMS (Seki et al., 2015).